US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist
  • 1.560
  • -0.010-0.64%
Close Aug 16 16:00 ET
  • 1.550
  • -0.010-0.63%
Post 20:02 ET
12.61MMarket Cap-189P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.21%-5.49M
-23.30%-3.83M
-104.20%-26.98M
-33.80%-5.19M
-13.52M
-5.17M
-3.11M
-69.98%-13.21M
-3.88M
-61.09%-7.77M
Net income from continuing operations
53.87%-5.77M
-11.81%-7.23M
-14.90%-29.22M
-6.10%-8.23M
---2.02M
---12.5M
---6.46M
-132.57%-25.43M
---7.76M
-37.75%-10.93M
Operating gains losses
----
----
--476K
--5K
----
----
----
----
----
-1,112.96%-655K
Depreciation and amortization
3.85%378K
104.37%374K
396.44%1.26M
343.90%364K
--345K
--364K
--183K
65.36%253K
--82K
30.77%153K
Other non cash items
-99.46%16K
-92.56%16K
-13.97%1.93M
-165.81%-1.46M
--201K
--2.98M
--215K
209.22%2.25M
--2.21M
844.16%727K
Change In working capital
17.16%-777K
19,070.00%1.92M
-274.89%-6.24M
1,066.99%2.99M
---8.3M
---938K
--10K
225.34%3.57M
---309K
16.08%1.1M
-Change in prepaid assets
102.48%7K
656.54%1.58M
-1,405.29%-2.22M
-137.84%-352K
---1.3M
---282K
---283K
141.46%170K
---148K
-736.73%-410K
-Change in payables and accrued expense
-20.86%-533K
125.68%580K
-244.01%-4.9M
1,381.37%2.06M
---6.77M
---441K
--257K
125.55%3.4M
---161K
51.61%1.51M
-Change in other current liabilities
-16.74%-251K
-761.11%-238K
--872K
--1.28M
---226K
---215K
--36K
--0
--0
----
Cash from discontinued investing activities
Operating cash flow
-6.21%-5.49M
-23.30%-3.83M
-104.20%-26.98M
-33.80%-5.19M
---13.52M
---5.17M
---3.11M
-69.98%-13.21M
---3.88M
-61.09%-7.77M
Investing cash flow
Cash flow from continuing investing activities
0
96.35%-5K
3.24%-478K
78.26%-35K
-63K
-243K
-137K
-129.77%-494K
-161K
44.59%-215K
Net PPE purchase and sale
--0
96.35%-5K
-36.68%-585K
56.52%-70K
---72K
---306K
---137K
-107.77%-428K
---161K
41.31%-206K
Net business purchase and sale
----
----
--9K
--0
----
----
----
--0
--0
----
Net investment purchase and sale
----
----
----
----
--0
----
----
----
----
----
Net other investing changes
----
----
248.48%98K
----
----
----
----
-633.33%-66K
----
75.68%-9K
Cash from discontinued investing activities
Investing cash flow
--0
96.35%-5K
3.24%-478K
78.26%-35K
---63K
---243K
---137K
-129.77%-494K
---161K
44.59%-215K
Financing cash flow
Cash flow from continuing financing activities
-20.91%5.2M
-20.52%3.01M
140.29%29.04M
-168.49%-2.96M
21.64M
6.58M
3.79M
23.21%12.09M
4.32M
108.86%9.81M
Net issuance payments of debt
-306.34%-1.82M
36.29%3.18M
-34.90%899K
-255.59%-2.3M
---17K
--883K
--2.33M
-21.09%1.38M
--1.48M
-6.87%1.75M
Net common stock issuance
----
----
--2.76M
--0
--2.76M
----
----
--0
--0
-98.83%35K
Net preferred stock issuance
----
----
--24.5M
--0
--19.35M
----
----
--0
--0
--0
Cash dividends paid
--0
--0
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
4,384.00%2.24M
--0
146.49%281K
--0
--50K
--50K
--181K
14.00%114K
--0
--100K
Net other financing activities
-89.67%153K
-112.67%-162K
-94.30%604K
-123.22%-660K
---1.5M
--1.48M
--1.28M
33.65%10.59M
--2.84M
198,225.00%7.93M
Cash from discontinued financing activities
Financing cash flow
-20.91%5.2M
-20.52%3.01M
140.29%29.04M
-168.49%-2.96M
--21.64M
--6.58M
--3.79M
23.21%12.09M
--4.32M
108.86%9.81M
Net cash flow
Beginning cash position
19.70%1.36M
267.29%2.17M
-73.63%590K
3,355.00%10.37M
--2.29M
--1.14M
--590K
432.62%2.24M
--300K
-55.03%420K
Current changes in cash
-125.37%-294K
-250.46%-823K
197.66%1.58M
-3,000.35%-8.18M
--8.06M
--1.16M
--547K
-189.02%-1.62M
--282K
452.22%1.82M
Effect of exchange rate changes
-30.00%-13K
--17K
76.92%-6K
-337.50%-19K
--23K
---10K
--0
-550.00%-26K
--8K
-233.33%-4K
End cash Position
-53.89%1.05M
19.70%1.36M
267.29%2.17M
267.29%2.17M
--10.37M
--2.29M
--1.14M
-73.63%590K
--590K
432.62%2.24M
Free cash flow
-0.27%-5.49M
-18.25%-3.84M
-102.08%-27.57M
-30.20%-5.26M
---13.59M
---5.48M
---3.24M
-70.95%-13.64M
---4.04M
-54.14%-7.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.21%-5.49M-23.30%-3.83M-104.20%-26.98M-33.80%-5.19M-13.52M-5.17M-3.11M-69.98%-13.21M-3.88M-61.09%-7.77M
Net income from continuing operations 53.87%-5.77M-11.81%-7.23M-14.90%-29.22M-6.10%-8.23M---2.02M---12.5M---6.46M-132.57%-25.43M---7.76M-37.75%-10.93M
Operating gains losses ----------476K--5K---------------------1,112.96%-655K
Depreciation and amortization 3.85%378K104.37%374K396.44%1.26M343.90%364K--345K--364K--183K65.36%253K--82K30.77%153K
Other non cash items -99.46%16K-92.56%16K-13.97%1.93M-165.81%-1.46M--201K--2.98M--215K209.22%2.25M--2.21M844.16%727K
Change In working capital 17.16%-777K19,070.00%1.92M-274.89%-6.24M1,066.99%2.99M---8.3M---938K--10K225.34%3.57M---309K16.08%1.1M
-Change in prepaid assets 102.48%7K656.54%1.58M-1,405.29%-2.22M-137.84%-352K---1.3M---282K---283K141.46%170K---148K-736.73%-410K
-Change in payables and accrued expense -20.86%-533K125.68%580K-244.01%-4.9M1,381.37%2.06M---6.77M---441K--257K125.55%3.4M---161K51.61%1.51M
-Change in other current liabilities -16.74%-251K-761.11%-238K--872K--1.28M---226K---215K--36K--0--0----
Cash from discontinued investing activities
Operating cash flow -6.21%-5.49M-23.30%-3.83M-104.20%-26.98M-33.80%-5.19M---13.52M---5.17M---3.11M-69.98%-13.21M---3.88M-61.09%-7.77M
Investing cash flow
Cash flow from continuing investing activities 096.35%-5K3.24%-478K78.26%-35K-63K-243K-137K-129.77%-494K-161K44.59%-215K
Net PPE purchase and sale --096.35%-5K-36.68%-585K56.52%-70K---72K---306K---137K-107.77%-428K---161K41.31%-206K
Net business purchase and sale ----------9K--0--------------0--0----
Net investment purchase and sale ------------------0--------------------
Net other investing changes --------248.48%98K-----------------633.33%-66K----75.68%-9K
Cash from discontinued investing activities
Investing cash flow --096.35%-5K3.24%-478K78.26%-35K---63K---243K---137K-129.77%-494K---161K44.59%-215K
Financing cash flow
Cash flow from continuing financing activities -20.91%5.2M-20.52%3.01M140.29%29.04M-168.49%-2.96M21.64M6.58M3.79M23.21%12.09M4.32M108.86%9.81M
Net issuance payments of debt -306.34%-1.82M36.29%3.18M-34.90%899K-255.59%-2.3M---17K--883K--2.33M-21.09%1.38M--1.48M-6.87%1.75M
Net common stock issuance ----------2.76M--0--2.76M----------0--0-98.83%35K
Net preferred stock issuance ----------24.5M--0--19.35M----------0--0--0
Cash dividends paid --0--0--------------0--0------------
Proceeds from stock option exercised by employees 4,384.00%2.24M--0146.49%281K--0--50K--50K--181K14.00%114K--0--100K
Net other financing activities -89.67%153K-112.67%-162K-94.30%604K-123.22%-660K---1.5M--1.48M--1.28M33.65%10.59M--2.84M198,225.00%7.93M
Cash from discontinued financing activities
Financing cash flow -20.91%5.2M-20.52%3.01M140.29%29.04M-168.49%-2.96M--21.64M--6.58M--3.79M23.21%12.09M--4.32M108.86%9.81M
Net cash flow
Beginning cash position 19.70%1.36M267.29%2.17M-73.63%590K3,355.00%10.37M--2.29M--1.14M--590K432.62%2.24M--300K-55.03%420K
Current changes in cash -125.37%-294K-250.46%-823K197.66%1.58M-3,000.35%-8.18M--8.06M--1.16M--547K-189.02%-1.62M--282K452.22%1.82M
Effect of exchange rate changes -30.00%-13K--17K76.92%-6K-337.50%-19K--23K---10K--0-550.00%-26K--8K-233.33%-4K
End cash Position -53.89%1.05M19.70%1.36M267.29%2.17M267.29%2.17M--10.37M--2.29M--1.14M-73.63%590K--590K432.62%2.24M
Free cash flow -0.27%-5.49M-18.25%-3.84M-102.08%-27.57M-30.20%-5.26M---13.59M---5.48M---3.24M-70.95%-13.64M---4.04M-54.14%-7.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg